Position in REGN
as of Mar 31, 2026
· filed Apr 7, 2026
Position Value
$259,607
-$34,475 QoQ
Shares Held
336
-11.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Green Alpha Advisors, LLC holds $7,875,497 across 13 Biotechnology names. REGN ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
57,022 | $2,712,536 | |
| 2 | MRNA |
Moderna, Inc.
|
34,338 | $1,744,370 | |
| 3 | CRBU |
Caribou Biosciences, Inc.
|
373,650 | $709,935 | |
| 4 | PRME |
Prime Medicine, Inc.
|
191,171 | $665,275 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
|
152,098 | $466,940 | |
| 6 | EDIT |
Editas Medicine, Inc.
|
160,142 | $395,550 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
336 | $259,607 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
546 | $243,810 |
All Filings in REGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $259,607 | 336 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $294,082 | 381 | Shares | Sole | 2026-01-07 | |
| 2025-03-31 | $218,175 | 344 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $255,014 | 358 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $401,573 | 382 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $437,228 | 416 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $450,445 | 468 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $404,891 | 461 | Shares | Sole | 2024-01-05 | |
| 2023-09-30 | $437,814 | 532 | Shares | Sole | 2023-10-10 | |
| No filing history on record for this holder in this stock. | ||||||